PHA 665752

• Supplier: R&D Systems
• Catalog: 2693
• Prices: $289.00, $1,185.00
• Sizes: 10 mg, 50 mg
• Cas Number: 477575-56-7
• Chemical Name: (2R)-1-[[5-[(Z)-[5-[[(2,6-Dichlorophenyl)methyl]sulfonyl]-1,2-dihydro-2-oxo-3H-indol-3-ylidene]methyl]-2,4-dimethyl-1H-pyrrol-3-yl]carbonyl]-2-(1-pyrrolidinylmethyl)pyrrolidine
• Formula: C32H34Cl2N4O4S
• Molecular Weight: 641.61
• Purity: >98%

Product References

Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells Derived from Human - Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells Derived from Human

Valente S, Ciavarella C, Pasanisi E, Ricci F, Stella A, Pasquinelli G. Stem Cells Int. 2016;2016:3232859.

Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells - Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells

Ito Y, Correll K, Zemans RL, Leslie CC, Murphy RC, Mason RJ. Am J Physiol Lung Cell Mol Physiol. 2015 Jun 1;308(11):L1178-88. doi:

The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and - The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and

Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T. BMC Cancer. 2015 Feb 25;15:82.

YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of - YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of

Jiang WG, Ye L, Ruge F, Owen S, Martin T, Sun PH, Sanders AJ, Lane J, Satherley L, Weeks HP, Gao Y, Wei C, Wu Y, Mason MD. J Transl Med. 2015 Aug 27;13:280.

C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating - C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating

Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, Huang MC. Cancer Res. 2013 Sep 1;73(17):5580-90.

EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma - EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma

Breindel JL, Haskins JW, Cowell EP, Zhao M, Nguyen DX, Stern DF. Cancer Res. 2013 Aug 15;73(16):5053-65.

Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition. - Cytotoxic activity of tivantinib (ARQ 197) is not due solely to c-MET inhibition.

Katayama R, Aoyama A, Yamori T, Qi J, Oh-hara T, Song Y, Engelman JA, Fujita N. Cancer Res. 2013 May 15;73(10):3087-96.

A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance - A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance

Grugan KD, Vega ME, Wong GS, Diehl JA, Bass AJ, Wong KK, Nakagawa H, Rustgi AK. Cancer Biol Ther. 2013 Sep;14(9):853-9.

Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent - Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent

Accornero P, Miretti S, Bersani F, Quaglino E, Martignani E, Baratta M. PLoS One. 2012;7(9):e44982.

Inhibition of hepcidin transcription by growth factors. - Inhibition of hepcidin transcription by growth factors.

Goodnough JB, Ramos E, Nemeth E, Ganz T. Hepatology. 2012 Jul;56(1):291-9.